Publications by authors named "Jennifer Ka Wah Wong"
Intraperitoneal (IP) administration of antibiotics is a preferred treatment of peritoneal dialysis (PD)-related peritonitis. Given the treatment duration of up to 2-3 weeks, it is important that robust data on antibiotic stability and compatibility are available to achieve notable treatment success. This article provides a comprehensive review of recent stability and compatibility studies pertaining to a wide range of antibiotics admixed in various PD solutions.
View Article and Find Full Text PDFArticle Synopsis
- Peritoneal dialysis (PD)-associated peritonitis poses significant risks, and the 2022 ISPD updates provide clearer definitions and recommendations to reduce its occurrence and improve patient outcomes.
- New categories such as pre-PD peritonitis and enteric peritonitis are introduced, with goals set at less than 0.40 episodes per year and over 80% of patients free of peritonitis.
- The updates also focus on management strategies, including addressing modifiable risk factors, enhancing antibiotic protocols, and calling for further research in prevention and treatment approaches.